Scottsdale, Arizona Jun 12, 2021 (Issuewire.com) - Praxsyn Corporate Update
Corporate Developments and Future Plans
Praxsyn Corporation’s (OTC: PXYN, the “Company”) subsidiary, Mesa Pharmacy, Inc., through its attorneys, had filed a Petition for Reconsideration of the Findings of Fact and Opinion on Decision regarding its pending litigation in California before the Workers’ Compensation Appeals Board. The Company has now received further guidance regarding the case through its attorneys. The Workers’ Compensation Appeals Board of the State of California has issued an Opinion and Order Granting Petition For Reconsideration for the purpose of further deciding the substantive issues in the case. The Company’s counsel has advised that, as a consequence of this decision, all further Writs would have stayed and as a consequence, the planned preparation of the appeal to the California Courts of Appeal has been postponed. Counsel has advised, based on prior experience, it could take until the end of the year to adjudicate these claims. The Company is still working on becoming current with its filings and will continue to update shareholders periodically.
About Praxsyn Corporation
Headquartered in Scottsdale, Arizona, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statement This Press Release contains forward-looking statements that involve risks and uncertainties, which may include statements about business strategy and development plans, plans for entering a new business, anticipated sources of funds, including proceeds from future operations and plans, objectives, expectations, and intentions contained in the Press Release that are not historical facts such as “estimated gross”…prospective resources, total potential revenue, substantially exceeds, etc. “Because these forward-looking statements involve risk and uncertainties, actual results could differ materially from those discussed in this Press Release.
Media Contact
Praxsyn Corporation d.oswald@praxsyncapital.com 4807888782 7904 E Chaparral Rd, Ste A110-210 http://praxsyn.com
